症状性颅内动脉狭窄治疗方式的研究进展
|
摘要
症状性颅内动脉狭窄近年来的发病率逐年升高,且呈年轻化发展,术后症状的改善及预后成为了主要研究热点,其治疗方式主要有开颅手术治疗、药物治疗、血管内介入治疗。目前,随着治疗水平、材料和设备均得到改进,治疗方式也更加多元化。现就近年来颅内动脉狭窄治疗方式的研究现状做一综述。
In recent years, the incidence of symptomatic intracranial artery stenosis has increased year by year, and the onset age tendency of it has become more younger. The improvement of postoperative symptoms and prognosis have become the main research hotspots. The treatment methods mainly include craniotomy, drug therapy, and endovascular intervention treatment. At present, as treatment levels, materials and equipment are improved, the treatments are more diverse. Now we have a recapitulate for the current research status of the treatment of intracranial artery stenosis.
In recent years, the incidence of symptomatic intracranial artery stenosis has increased year by year, and the onset age tendency of it has become more younger. The improvement of postoperative symptoms and prognosis have become the main research hotspots. The treatment methods mainly include craniotomy, drug therapy, and endovascular intervention treatment. At present, as treatment levels, materials and equipment are improved, the treatments are more diverse. Now we have a recapitulate for the current research status of the treatment of intracranial artery stenosis.
引文
[1]尹榕.颅内动脉粥样硬化性狭窄介入治疗的有效性和安全性评估研究[J].第二军医学,2014:1-122.
[2]Wong LK.Global burden of intracrani alatherosclerosis[J].IntJ Stroke,2006,1(3):158-9.
[3]孟然,郭秀海,吉训明.颅内动脉狭窄的缺血适应防治方法和策略[J].中华老年心脑血管病杂志,2017,19(2):223-224.
[4]Kim JS, Bang OY. Medical Treatment of Intracranial Atherosclerosis:An Update[J].J Stroke,2017,19(3):261-270.
[5]Furie KL, Kasner SE, Adams RJ, et al.Guidelines for the prevention of stroke in patients withstroke or transient ischemic attack:a guideline for healthcare professionals from the american heart association/american stroke association[J]. Stroke,2011,42(1):227-76.
[6]SiddiqF,AdilMM,NorbyK,etal.Intracranialstentplacement forsymptomatic intracranial stenosis as part of a clinical trial versus outside aclinical trial[J]. Stroke,2013,44(12):3571-2.
[7]Millikan CH, Siekert RG, Shick RM. Studies in cerebrovascular disease. III.The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system[J]. Proc Staff Meet Mayo Clin,1955,30(6):116-126.
[8]Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparisonof warfarin and aspirin for symptomatic intracranial arterial stenosis[J]. N Engl J Med,2005,352(13):1305-16.
[9]覃星悦.粥样硬化性颅内动脉狭窄治疗的研究进展[J].医学综述,2013,19(21):3897-3899.
[10]Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis[J]. Circulation,2006,113(4):555-63.
[11]张海涛,曾仲,高励,等.支架与药物治疗颅内动脉狭窄中长期疗效分析[J].四川医学,2016,37(11):1202-1205.
[12]Gao P, Zhao Z, Wang D, et al. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis(CASSISS):A new, prospective,multicenter, randomized controlled trial in China[J]. IntervNeuroradiol,2015,21(2):196-204.
[13]蔡乾昆,陈茂刚,李永坤,等.血管内介入与单纯药物治疗重度颅内前循环动脉狭窄的长期疗效比较[J].中华神经科杂志,2013,46(1):42-46.
[14]凌芳,华梅.症状性颅内动脉狭窄支架置入术后患者的心理变化[J].神经损伤与功能重建,2014,(5):443-444.
[15]Schnaudigel S, Gr?schel K, Pilgram SM, et al. New brain lesions after carotid stenting versus carotid endarterectomy:a systematic review of the literature[J]. Stroke,2008,39(6):1911-1919.
[16]Lutsep HL, Lynn MJ, Cotsonis GA, et al.SAMMPRIS Investigators. Does the StentingVersus Aggressive Medical Therapy Trial Support Stenting for Subgroups WithIntracranial Stenosis?[J]. Stroke,2015,46(11):3282-3284.
[17]Al Hasan M, Murugan R. Stenting versus aggressive medical therapy forintracranialarterialstenosis:moreharmthangood[J].Crit Care,2012,16(3):310.
[18]陈茹,张念军,赵敏,等.支架与药物治疗症状性颅内动脉狭窄远期疗效对比[J].介入放射学杂志,2016,25(2):97-101.
[19]侯永革,王菁,刘燚隆,等.血管内治疗与药物治疗症状性颅内动脉狭窄的疗效比较[J].中国脑血管病杂志,2014,(6):294-299.
[20]Chimowitz MI, Derdeyn CP. Endovascular therapy for atherosclerotic intracranialarterialstenosis:backtothedrawingboard[J].JAMA,2015,313(12):1219-1220.
[21]王根,曹毅.颈动脉支架置入术后再狭窄的病理生理学机制[J].国际脑血管病杂志,2016,24(10):936-939.G22
[22]刘建光,姜红梅,王铮,等.支架成形术治疗老年重度颅内动脉狭窄患者的疗效[J].神经损伤与功能重建,2016,11(5):395-397.
[23]刘一强,杜丽娟,王天玉.血管内介入与单纯药物治疗老年重度颅内前循环动脉狭窄的疗效[J].中国老年学杂志,2015,(1):70-71.
[24]Chimowitz MI, Lynn MJ, Derdeyn CP, et al.Stenting versus aggressive medical therapy for intracranial arterial stenosis[J].NEnglJ Med,2011365(11):993-1003.
[25]Colin P, Derdeyn,Marc I, Chimowitz,Michael J, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis(SAMMPRIS):the final results of a randomised trial[J].Lancet(London, England),2014,383(9914):333-341.
[26]Mohammadian R, Pashapour A, Sharifipour E, et al. A Comparison of Stent Implant versus Medical Treatment for Severe Symptomatic Intracranial Stenosis:A ControlledClinical Trial[J]. Cerebrovasc Dis Extra,2012,2(1):108-20.
[27]黄清海,刘建民,许奕,等.不同类型支架的血管成形术治疗颅内动脉狭窄对比研究[J].中华神经外科杂志,2009,25(5):432-435.
[28]刘楠,张广平,李慎茂,等.支架与药物治疗症状性颅内动脉狭窄的对比研究[J].中国脑血管病杂志,2012,09(9):483-485.
[29]Terroni LDN, Mattos PF, Sobreiro MDM, et al. Post-stroke depression:psychological, neuropsychological, HHA axis, localization of stroke aspects and treatment[J]. Revista de PsiquiatriaClinica, 2009, 36:100-108.
[30]Hama S, Yamashita H, Shigenobu M, et al. Post-stroke affective or apathetic depression and lesion location:left frontal lobe and bilateral basal ganglia[J].Eur Arch Psychiatry ClinNeu-rosci, 2007, 257:149-152.
[31]Paola, Bossù,Francesca, et al. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke[J].Current neurovascular research,2009,6(3):163-70.
[32]Kuo HK, Yen CJ, Chang CH,et al. Relation of C-reactiveprotein to stroke,cognitive disorders, and depression in the general population:systematic review and meta-analysis[J]. Lancet Neurol, 2005,4(6):371-80.
[33]Markus HS, Droste DW, Kaps M,et al.Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection:the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis(CARESS)trial[J].Circulati on,2005,111(17):2233-40.
[2]Wong LK.Global burden of intracrani alatherosclerosis[J].IntJ Stroke,2006,1(3):158-9.
[3]孟然,郭秀海,吉训明.颅内动脉狭窄的缺血适应防治方法和策略[J].中华老年心脑血管病杂志,2017,19(2):223-224.
[4]Kim JS, Bang OY. Medical Treatment of Intracranial Atherosclerosis:An Update[J].J Stroke,2017,19(3):261-270.
[5]Furie KL, Kasner SE, Adams RJ, et al.Guidelines for the prevention of stroke in patients withstroke or transient ischemic attack:a guideline for healthcare professionals from the american heart association/american stroke association[J]. Stroke,2011,42(1):227-76.
[6]SiddiqF,AdilMM,NorbyK,etal.Intracranialstentplacement forsymptomatic intracranial stenosis as part of a clinical trial versus outside aclinical trial[J]. Stroke,2013,44(12):3571-2.
[7]Millikan CH, Siekert RG, Shick RM. Studies in cerebrovascular disease. III.The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system[J]. Proc Staff Meet Mayo Clin,1955,30(6):116-126.
[8]Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparisonof warfarin and aspirin for symptomatic intracranial arterial stenosis[J]. N Engl J Med,2005,352(13):1305-16.
[9]覃星悦.粥样硬化性颅内动脉狭窄治疗的研究进展[J].医学综述,2013,19(21):3897-3899.
[10]Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis[J]. Circulation,2006,113(4):555-63.
[11]张海涛,曾仲,高励,等.支架与药物治疗颅内动脉狭窄中长期疗效分析[J].四川医学,2016,37(11):1202-1205.
[12]Gao P, Zhao Z, Wang D, et al. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis(CASSISS):A new, prospective,multicenter, randomized controlled trial in China[J]. IntervNeuroradiol,2015,21(2):196-204.
[13]蔡乾昆,陈茂刚,李永坤,等.血管内介入与单纯药物治疗重度颅内前循环动脉狭窄的长期疗效比较[J].中华神经科杂志,2013,46(1):42-46.
[14]凌芳,华梅.症状性颅内动脉狭窄支架置入术后患者的心理变化[J].神经损伤与功能重建,2014,(5):443-444.
[15]Schnaudigel S, Gr?schel K, Pilgram SM, et al. New brain lesions after carotid stenting versus carotid endarterectomy:a systematic review of the literature[J]. Stroke,2008,39(6):1911-1919.
[16]Lutsep HL, Lynn MJ, Cotsonis GA, et al.SAMMPRIS Investigators. Does the StentingVersus Aggressive Medical Therapy Trial Support Stenting for Subgroups WithIntracranial Stenosis?[J]. Stroke,2015,46(11):3282-3284.
[17]Al Hasan M, Murugan R. Stenting versus aggressive medical therapy forintracranialarterialstenosis:moreharmthangood[J].Crit Care,2012,16(3):310.
[18]陈茹,张念军,赵敏,等.支架与药物治疗症状性颅内动脉狭窄远期疗效对比[J].介入放射学杂志,2016,25(2):97-101.
[19]侯永革,王菁,刘燚隆,等.血管内治疗与药物治疗症状性颅内动脉狭窄的疗效比较[J].中国脑血管病杂志,2014,(6):294-299.
[20]Chimowitz MI, Derdeyn CP. Endovascular therapy for atherosclerotic intracranialarterialstenosis:backtothedrawingboard[J].JAMA,2015,313(12):1219-1220.
[21]王根,曹毅.颈动脉支架置入术后再狭窄的病理生理学机制[J].国际脑血管病杂志,2016,24(10):936-939.G22
[22]刘建光,姜红梅,王铮,等.支架成形术治疗老年重度颅内动脉狭窄患者的疗效[J].神经损伤与功能重建,2016,11(5):395-397.
[23]刘一强,杜丽娟,王天玉.血管内介入与单纯药物治疗老年重度颅内前循环动脉狭窄的疗效[J].中国老年学杂志,2015,(1):70-71.
[24]Chimowitz MI, Lynn MJ, Derdeyn CP, et al.Stenting versus aggressive medical therapy for intracranial arterial stenosis[J].NEnglJ Med,2011365(11):993-1003.
[25]Colin P, Derdeyn,Marc I, Chimowitz,Michael J, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis(SAMMPRIS):the final results of a randomised trial[J].Lancet(London, England),2014,383(9914):333-341.
[26]Mohammadian R, Pashapour A, Sharifipour E, et al. A Comparison of Stent Implant versus Medical Treatment for Severe Symptomatic Intracranial Stenosis:A ControlledClinical Trial[J]. Cerebrovasc Dis Extra,2012,2(1):108-20.
[27]黄清海,刘建民,许奕,等.不同类型支架的血管成形术治疗颅内动脉狭窄对比研究[J].中华神经外科杂志,2009,25(5):432-435.
[28]刘楠,张广平,李慎茂,等.支架与药物治疗症状性颅内动脉狭窄的对比研究[J].中国脑血管病杂志,2012,09(9):483-485.
[29]Terroni LDN, Mattos PF, Sobreiro MDM, et al. Post-stroke depression:psychological, neuropsychological, HHA axis, localization of stroke aspects and treatment[J]. Revista de PsiquiatriaClinica, 2009, 36:100-108.
[30]Hama S, Yamashita H, Shigenobu M, et al. Post-stroke affective or apathetic depression and lesion location:left frontal lobe and bilateral basal ganglia[J].Eur Arch Psychiatry ClinNeu-rosci, 2007, 257:149-152.
[31]Paola, Bossù,Francesca, et al. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke[J].Current neurovascular research,2009,6(3):163-70.
[32]Kuo HK, Yen CJ, Chang CH,et al. Relation of C-reactiveprotein to stroke,cognitive disorders, and depression in the general population:systematic review and meta-analysis[J]. Lancet Neurol, 2005,4(6):371-80.
[33]Markus HS, Droste DW, Kaps M,et al.Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection:the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis(CARESS)trial[J].Circulati on,2005,111(17):2233-40.